Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 30, 2013New England Journal of Medicine

Brain Dopamine–Serotonin Vesicular Transport Disease and Its Treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

JRJennifer J. RilstoneUniversity of TorontoRAReem A. AlkhaterJohns Hopkins UniversityBMBerge A. MinassianUniversity of Chicago

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rilstone et al. (2013) studied this question.

synapsesocial.com/papers/69da21f6b48bb130d4684283https://doi.org/10.1056/nejmoa1207281
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Missense mutations in transmembrane domains of proteins: Phenotypic propensity of polar residues for human disease2004 · 108 citations
  2. 2Amino Acid Difference Formula to Help Explain Protein Evolution1974 · 2,467 citations
  3. 3Functional Identification and Molecular Cloning of a Human Brain Vesicle Monoamine Transporter1993 · 158 citations
  4. 4Whole-Genome Sequencing for Optimized Patient Management2011 · 302 citations